Evolutionary Genomics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 19, 2020 at 11:21 pm IST
Share
Evolutionary Genomics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 310,597 compared to USD 171,327 a year ago. Net loss was USD 294,798 compared to USD 181,745 a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.04 a year ago. For the half year, operating loss was USD 540,414 compared to USD 383,678 a year ago. Net loss was USD 536,614 compared to USD 382,142 a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.09 a year ago.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.
EVOLUTIONARY GENOMICS, INC. 
